Evolus, Inc.

NASDAQ (USD): Evolus, Inc. (EOLS)

Last Price

9.47

Today's Change

-0.33 (3.36%)

Day's Change

9.25 - 9.89

Trading Volume

702,712

Overview

Market Cap

599 Million

Shares Outstanding

63 Million

Avg Volume

630,890

Avg Price (50 Days)

12.52

Avg Price (200 Days)

13.36

PE Ratio

-10.41

EPS

-0.91

Earnings Announcement

05-Mar-2025

Previous Close

9.80

Open

9.80

Day's Range

9.25 - 9.89

Year Range

9.25 - 17.82

Trading Volume

723,457

Price Change Highlight

1 Day Change

-3.37%

5 Day Change

-5.86%

1 Month Change

-17.72%

3 Month Change

-43.29%

6 Month Change

-21.54%

Ytd Change

-14.76%

1 Year Change

-9.20%

3 Year Change

81.42%

5 Year Change

-12.64%

10 Year Change

-17.65%

Max Change

-17.65%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Drug Manufacturers—Specialty & Generic

Description:

Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment